Document is current
Any future updates will be listed below
-
Authors
Kaufmann, Horacio https://orcid.org/0000-0002-1851-9981
Vickery, Ross
Wang, Whedy
Kanodia, Jitendra
Shibao, Cyndya A.
Norcliffe-Kaufmann, Lucy
Haumann, Brett
Biaggioni, Italo
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02705755 at ClinicalTrials.govDocuments that mention this clinical trial
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
https://doi.org/10.1007/s10286-021-00827-0
-
Funding
Funding for this research was provided by:
Theravance Biopharma R&D, Inc.
- License Information
-
More Information
Article History
Received: 26 May 2021
Accepted: 8 September 2021
First Online: 17 October 2021
Declarations
:
: HK was a consultant to and has received research support from Theravance Biopharma US, Inc. RV is an employee of Theravance Biopharma Ireland Limited and stockholder of Theravance Biopharma, Inc. WW is a former employee of Theravance Biopharma US, Inc. JK is an employee of Theravance Biopharma US, Inc. and a stockholder of Theravance Biopharma, Inc. CS has received research support from Theravance Biopharma and is a member of the Advisory Board of Lundbeck US. LNK is an employee of Theravance Biopharma US, Inc. BH is a former employee of Theravance Biopharma UK Limited and a stockholder of Theravance Biopharma, Inc. IB is a consultant for and has received research support from Theravance Biopharma and is a patent holder of an automated abdominal binder for the treatment of orthostatic hypotension.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Local IRB approvals were obtained.
: Informed consent was obtained from all individual participants in the study.
: All authors have approved the final draft and agree to have these data published.
